浏览全部资源
扫码关注微信
1.陕西中医药大学 第一临床医学院,陕西 咸阳 712046
2.北京中医药大学 教育部中医养生学重点实验室,北京 100029
3.成都中医药大学,成都 610075
Published:20 February 2023,
Published Online:13 October 2022,
Received:22 June 2022,
扫 描 看 全 文
杨鹏,刘铜华,吴丽丽等.中药皂苷类成分干预糖尿病肾病作用机制研究进展[J].中国实验方剂学杂志,2023,29(04):263-271.
YANG Peng,LIU Tonghua,WU Lili,et al.Mechanisms of Saponins in Chinese Medicinals Against Diabetic Nephropathy: A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(04):263-271.
杨鹏,刘铜华,吴丽丽等.中药皂苷类成分干预糖尿病肾病作用机制研究进展[J].中国实验方剂学杂志,2023,29(04):263-271. DOI: 10.13422/j.cnki.syfjx.20222337.
YANG Peng,LIU Tonghua,WU Lili,et al.Mechanisms of Saponins in Chinese Medicinals Against Diabetic Nephropathy: A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(04):263-271. DOI: 10.13422/j.cnki.syfjx.20222337.
糖尿病肾病(DN)是糖尿病最严重的微血管并发症,也是糖尿病最常见和最严重的并发症之一,是世界范围内终末期肾病的主要原因,是糖尿病患者发病和死亡的主要原因,也是全球最大的非传染性死亡原因。皂苷类化合物种类众多,是许多中草药的主要生物活性成分,具有降血糖、降脂、改善胰岛素抵抗、抗炎、抗氧化应激、抗肿瘤、调节免疫等多种药理活性。近些年来,许多实验研究显示,中药皂苷类活性成分调控DN疗效明确。中药皂苷干预糖尿病肾病具有多靶点、多信号通路、多系统、多效应的特点和作用。在防治DN上具有广阔前景。目前体内外关于中药皂苷类成分干预DN的研究众多,但是缺乏系统的、全面的对中药皂苷类成分干预DN的研究的整理、概括、综述,所以对近年来国内外关于中药皂苷类干预DN模型的实验研究进行总结,对其通过改善糖脂代谢、抑制氧化应激、抗炎、抗细胞凋亡、调节自噬、抗纤维化、保护足细胞等途径缓解DN的机制进行阐述,以期为DN相关防治药物的研发提供思路和参考。
Diabetic nephropathy (DN), the most feared microvascular complication of diabetes and one of the most common and serious complications of diabetes, is the major cause of end-stage renal disease worldwide, leading cause of morbidity and mortality in patients with diabetes, and the main non-communicable cause of death worldwide. There are many types of saponins, which are the main bioactive components of various Chinese medicinals. They have various pharmacological activities such as lowering blood glucose and blood lipids, improving insulin resistance, anti-inflammation, anti-oxidative stress, anti-tumor, and immune modulation. In recent years, it has been frequently verified that the saponins in Chinese medicinals have definite effect in regulating DN, showing multi-target, multi-pathway, multi-system, multi-effect characteristics. Thus, they have broad prospects in the prevention and treatment of this disease. There has been an explosion of research on the treatment of DN with saponins in Chinese medicinals
in vivo
and
in vitro
, but there is a lack of systematic and comprehensive summary. Therefore, this study summed up the studies of saponins in Chinese medicinals in the intervention of DN and summarized the mechanisms such as improving glucolipid metabolism, inhibiting oxidative stress, anti-inflammation, anti-apoptosis, regulating autophagy, anti-fibrosis, and protecting podocytes, with a view to providing ideas and references for the development of drugs related to DN.
中药皂苷糖尿病肾病信号通路:作用机制
saponins in Chinese medicinalsdiabetic nephropathysignaling pathway: mechanism
XUE R,GUI D,ZHENG L,et al.Mechanistic insight and management of diabetic nephropathy:Recent progress and future perspective[J].J Diabetes Res,2017,2017:1839809.
LIN Y C,CHANG Y H,YANG S Y,et al.Update of pathophysiology and management of diabetic kidney disease[J].J Formos Med Assoc,2018,117(8):662-675.
SAMSU N.Diabetic nephropathy:Challenges in pathogenesis,diagnosis,and treatment[J].Biomed Res Int,2021,2021:1497449.
BRENNEMAN J,HILL J,PULLEN S.Emerging therapeutics for the treatment of diabetic nephropathy[J].Bioorg Med Chem Lett,2016,26(18):4394-4402.
刘云霄,黄英如,石一峰,等.人参皂苷Rg1对大鼠坐骨神经冷冻保存后SCs活性及异体移植后神经再生的影响[J].中国实验方剂学杂志,2022,28(13):52-61.
汪子翔,赵梅.皂苷类化合物抗肿瘤血管生成作用及机制研究进展[J].中华中医药杂志,2020,35(6):3029-3032.
王晶,刘春明,白鹤龙,等.中药中皂苷类化合物的抗氧化活性评价研究[J].时珍国医国药,2010,21(6):1485-1487.
KASHIHARA N,HARUNA Y,KONDETI V K,et al.Oxidative stress in diabetic nephropathy[J].Curr Med Chem,2010,17(34):4256-4269.
SIFUENTES-FRANCO S,PADILLA-TEJEDA D E,CARRILLO-IBARRA S,et al.Oxidative stress,apoptosis,and mitochondrial function in diabetic nephropathy[J].Int J Endocrinol,2018,2018:1875870.
MIRANDA-DÍAZ A G,PAZARÍN-VILLASEÑOR L,YANOWSKY-ESCATELL F G,et al.Oxidative stress in diabetic nephropathy with early chronic kidney disease[J].J Diabetes Res,2016,2016:7047238.
ØSTERGAARD J A,COOPER M E,JANDELEIT-DAHM K.Targeting oxidative stress and anti-oxidant defence in diabetic kidney disease[J].J Nephrol,2020,33(5):917-929.
吴浩,符丽珍,赵勇,等.桔梗皂苷D通过介导PI3K/Akt/mTOR信号通路调节氧化应激改善糖尿病肾病模型大鼠肾损伤[J].中国药理学与毒理学杂志,2022,36(3):170-176.
ZHONG Y,LIU J,SUN D,et al.Dioscin relieves diabetic nephropathy via suppressing oxidative stress and apoptosis,and improving mitochondrial quality and quantity control[J].Food Funct,2022,13(6):3660-3673.
ZHONG Y,LUO R,LIU Q,et al.Jujuboside A ameliorates high fat diet and streptozotocin induced diabetic nephropathy via suppressing oxidative stress,apoptosis,and enhancing autophagy[J].Food Chem Toxicol,2022,159:112697.
张晓利,胡威利,吴银,等.柴胡皂苷A对糖尿病大鼠肾结构和功能的保护作用及机制研究[J].广州中医药大学学报,2020,37(7):1347-1353.
张翠,王继胜,张根葆,等.芒果苷对STZ诱导的糖尿病大鼠肾脏的保护作用[J].皖南医学院学报,2017,36(4):314-317.
丁颖超,刘长山,李萍,等.甘草酸对糖尿病大鼠肾脏氧化应激及醛糖还原酶水平的影响[J].中日友好医院学报,2012,26(2):93-96.
SHAO B Y,ZHANG S F,LI H D,et al.Epigenetics and inflammation in diabetic nephropathy[J].Front Physiol,2021,12:649587.
LIU C,YANG M,LI L,et al.A Glimpse of inflammation and anti-inflammation therapy in diabetic kidney disease[J].Front Physiol,2022,13:909569.
PEREZ-MORALES R E,DEL PINO M D,VALDIVIELSO J M,et al.Inflammation in diabetic kidney disease[J].Nephron,2019,143(1):12-16.
DONATE-CORREA J,LUIS-RODRÍGUEZ D,MARTÍN-NÚÑEZ E,et al.Inflammatory targets in diabetic nephropathy[J].J Clin Med,2020,9(2):458.
田鲁,赵世莉,李红艳,等.楤木总皂苷对2型糖尿病肾病小鼠VEGF和MMP-9蛋白表达的影响[J].中国医师杂志,2019,21(5):682-687.
李易,田鲁,王港,等.苦瓜总皂苷对2型糖尿病肾病大鼠肾脏组织中单核细胞趋化蛋白1表达的影响[J].西部中医药,2017,30(6):8-12.
杨帆,刘春娜.三七叶苷对糖尿病肾病大鼠肾功能的保护作用研究[J].重庆医学,2022,51(6):916-919,923.
WANG S,YANG Z,XIONG F,et al.Betulinic acid ameliorates experimental diabetic-induced renal inflammation and fibrosis via inhibiting the activation of NF-κB signaling pathway[J].Mol Cell Endocrinol,2016,434:135-143.
THAKUR V,NARGIS S,GONZALEZ M,et al.Role of glycyrrhizin in the reduction of inflammation in diabetic kidney disease[J].Nephron,2017,137(2):137-147.
LIN J,CHENG A,CHENG K,et al.New insights into the mechanisms of pyroptosis and implications for diabetic kidney disease[J].Int J Mol Sci,2020,21(19):7057.
AL MAMUN A ,ARA MIMI A ,WU Y,et al.Pyroptosis in diabetic nephropathy[J].Clin Chim Acta,2021,523:131-143.
司芹芹,牛晓红,李俊岩,等.酸枣仁皂苷A对糖尿病模型大鼠肾小球细胞凋亡的影响[J].中国药理学与毒理学杂志,2017,31(5):399-404.
高崇婷,桂定坤,汪年松,等.黄芪皂苷Ⅱ对STZ诱导的糖尿病大鼠的肾脏保护作用研究[J].现代生物医学进展,2020,20(23):4401-4406,4417.
KOCH E,NAKHOUL R,NAKHOUL F,et al.Autophagy in diabetic nephropathy:A review[J].Int Urol Nephrol,2020,52(9):1705-1712.
CHEN J,CUI Y,ZHANG N,et al.Oleanolic acid attenuated diabetic mesangial cell injury by activation of autophagy via miRNA-142-5p/PTEN signaling[J].Cytotechnology,2019,71(5):925-933.
傅丹青,陈超,侯晓丽,等.绞股蓝总皂苷对高糖环境下小鼠肾脏足细胞自噬及mTOR/4EBP1/P70S6K信号通路的影响[J].中华中医药杂志,2021,36(5):2499-2502.
SU J,GAO C,XIE L,et al.Astragaloside Ⅱ ameliorated podocyte injury and mitochondrial dysfunction in streptozotocin-induced diabetic rats[J].Front Pharmacol,2021,12:638422.
SAKUMA H,HAGIWARA S,KANTHARIDIS P,et al.Potential targeting of renal fibrosis in diabetic kidney disease using microRNAs[J].Front Pharmacol,2020,11:587689.
陈伟,田鲁,王港,等.苦瓜总皂苷对2型糖尿病肾病大鼠肾脏细胞间纤连蛋白和胶原Ⅳ蛋白表达的影响[J].长春中医药大学学报,2016,32(2):237-240.
张少泉,李鑫辉,倪向荣.知母皂苷元通过AMPK-mTOR-ULK1途径抑制肾小球系膜基质合成和激活自噬治疗糖尿病肾病的研究[J].现代中西医结合杂志,2021,30(11):1180-1186.
栾仲秋.异黄芪皂苷Ⅳ对高糖诱导的肾小球系膜细胞活性的影响[J].北华大学学报:自然科学版,2020,21(2):179-183.
赵雷,张洪娜,陈锐,等.荔枝核皂苷对高糖诱导的HMC细胞增殖和凋亡的作用[J].时珍国医国药,2016,27(11):2566-2567.
彭静.黄精皂苷对糖尿病肾病大鼠肾损伤的保护作用及Wnt/β-catenin信号通路的影响[J].中成药,2019,41(10):2518-2521.
ZHANG L,WEN Z,HAN L,et al.Research progress on the pathological mechanisms of podocytes in diabetic nephropathy[J].J Diabetes Res,2020,2020:7504798.
尹江宁,汪华君,卢国元,等.熊果酸对糖尿病肾病大鼠足细胞损伤的保护作用[J].中国实验方剂学杂志,2018,24(17):132-138.
陈宇宁,吴晨光,钱珂,等.积雪草酸对糖尿病大鼠肾脏足细胞损伤的影响[J].中国新药与临床杂志,2014,33(10):741-746.
廖思勤.人参皂苷药理作用的研究[J].当代医药论丛,2022,20(12):20-23.
何道同,王兵,陈珺明.人参皂苷药理作用研究进展[J].辽宁中医药大学学报,2012,14(7):118-121.
杨敬,代俞燕,熊燕影,等.人参皂苷Rg1对糖尿病肾病大鼠血清氧化应激指标、炎性因子及肾组织TGF-β1、MCP-1 mRNA的影响[J].现代生物医学进展,2020,20(5):853-856,918.
韩宇,温玉玮,杜美娟,等.人参皂苷Rg1对高糖诱导的肾小管上皮细胞损伤保护作用[J].现代中药研究与实践,2021,35(5):38-42.
SONG W,WEI L,DU Y,et al.Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice[J].Int Immunopharmacol,2018,63:227-238.
李敬华,王素莉,沈继春,等.三七总皂苷对糖尿病肾病大鼠肾功能的作用研究[J].中华实用诊断与治疗杂志,2015,29(11):1075-1077.
董苏敏,胡相卡,赵苗鑫,等.三七总皂苷对糖尿病肾病小鼠的肾保护作用机制研究[J].中国临床药理学杂志,2021,37(17):2303-2307.
ZHANG B,ZHANG X,ZHANG C,et al.Notoginsenoside R1 protects db/db mice against diabetic nephropathy via upregulation of Nrf2-mediated HO-1 expression[J].Molecules,2019,24(2):247.
高利超,徐兵,刘永安,等.三七皂苷R1抑制TGF-β1/Smad3信号传导对糖尿病肾病大鼠肾脏纤维化和炎症细胞因子的调节作用研究[J].中国免疫学杂志,2020,36(10):1188-1193.
林琳,朱伟平,郑晶,等.三七总皂苷对高糖诱导的肾小管上皮细胞转分化的研究[J].时珍国医国药,2013,24(8):2053-2054.
杜月光,章科娜,姜雪儿,等.三七皂苷对高糖诱导的大鼠肾小球系膜细胞保护作用及其机制研究[J].浙江中医药大学学报,2015(9):647-653.
KIM H,KIM M,LEE H Y,et al.Role of dendritic cell in diabetic nephropathy[J].Int J Mol Sci,2021,22(14):7554.
SAWAF H,THOMAS G,TALIERCIO J J,et al.Therapeutic advances in diabetic nephropathy[J].J Clin Med,2022,11(2):378.
LU H C,DAI W N,HE L Y.Epigenetic histone modifications in the pathogenesis of diabetic kidney disease[J].Diabetes Metab Syndr Obes,2021,14:329-344.
LIU J Y,CHEN X X,TANG S C,et al.Chinese medicines in the treatment of experimental diabetic nephropathy[J].Chin Med,2016,11:6.
0
Views
20
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution